-
EditorialPublication 2020Diagnostic Testing for the Novel Coronavirus
This perspective provides insights about the controversies over diagnostic testing that have dominated U.S. headlines …
This perspective provides insights about the controversies over diagnostic testing that have dominated U.S. headlines regarding severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel coronavirus responsible for coronavirus disease-2019 (COVID-19). The authors review early testing challenges, beginning with the initial technical problems with the first test developed by the Centers for Disease Control and Prevention (CDC), which left the U.S. with inadequate diagnostic capacity early in the epidemic. They discuss the "diagnostic testing gap"…
Government/Law | Test Performance | Infectious Diseases | Policy/Regulation | Clinical Care | Health/Medicine | Science/Technology | North America -
EditorialPublication 2020Waiting for Certainty on COVID-19 Antibody Tests — At What Cost?
This perspective anticipates the availability of serologic antibody testing and considers its potential usefulness in mitigation …
This perspective anticipates the availability of serologic antibody testing and considers its potential usefulness in mitigation policy to reduce COVID-19 transmission. For example: Could we screen for serologic antibodies as a proxy for possible immunity and identify people who could return to the workplace with less severe mitigation measures? The authors acknowledge the uncertainties raised by many policy actors, including the WHO, such as, "Do antibodies confer immunity and, if so, for how long? How accurate is…
Government/Law | Probability/Bayes | Test Performance | Technology Assessment | Infectious Diseases | Health Systems | Policy/Regulation | Health/Medicine | Global | North America
2 Shown
General Resources
Teaching Resources
Collections
Format
Learner Level
Teaching Topic